BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
BGM Group (NASDAQ: BGM) announced it will release its unaudited financial results for the first half of 2025 before U.S. markets open on July 24, 2025 EDT. The China-based company's upcoming earnings release will provide investors with insights into its financial performance during the first six months of 2025.
BGM Group (NASDAQ: BGM) ha annunciato che pubblicherà i suoi risultati finanziari non revisionati per il primo semestre del 2025 prima dell'apertura dei mercati statunitensi il 24 luglio 2025, ora EDT. Il prossimo comunicato sugli utili della società cinese offrirà agli investitori una panoramica delle sue prestazioni finanziarie nei primi sei mesi del 2025.
BGM Group (NASDAQ: BGM) anunció que publicará sus resultados financieros no auditados del primer semestre de 2025 antes de la apertura de los mercados de EE. UU. el 24 de julio de 2025, hora EDT. El próximo informe de ganancias de esta compañía con sede en China brindará a los inversores información sobre su desempeño financiero durante los primeros seis meses de 2025.
BGM Group (NASDAQ: BGM)는 2025년 상반기 미감사 재무 실적을 2025년 7월 24일 EDT, 미국 시장 개장 전에 발표할 예정이라고 밝혔습니다. 중국에 본사를 둔 이 회사의 다가오는 실적 발표는 2025년 첫 6개월 동안의 재무 성과에 대한 투자자들의 이해를 돕는 자료가 될 것입니다.
BGM Group (NASDAQ : BGM) a annoncé qu'elle publiera ses résultats financiers non audités du premier semestre 2025 avant l'ouverture des marchés américains le 24 juillet 2025 à l'heure EDT. Cette prochaine publication des résultats de la société basée en Chine offrira aux investisseurs un aperçu de sa performance financière au cours des six premiers mois de 2025.
BGM Group (NASDAQ: BGM) gab bekannt, dass es seine unauditierten Finanzergebnisse für das erste Halbjahr 2025 vor der Öffnung der US-Märkte am 24. Juli 2025 EDT veröffentlichen wird. Die bevorstehende Gewinnmitteilung des in China ansässigen Unternehmens wird Investoren Einblicke in die finanzielle Leistung der ersten sechs Monate 2025 geben.
- None.
- None.
About BGM
BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals.
In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. Its services cover multiple key scenarios such as sales and marketing, underwriting assessment, claims processing, and customer service. The group is capable of analyzing consumer data, building consumer profiles, accurately predicting insurance needs, and providing highly customized services for consumers.
In the field of biopharmaceuticals, the group's biopharmaceutical division mainly produces oxytetracycline API, crude heparin sodium, and licorice preparations, which are widely supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The group deeply integrates AI-assisted decision-making into every link of production and manufacturing, achieving supply chain optimization, process efficiency improvement, and market trend prediction. This provides scientific decision-making basis for the management and offers high-quality products and precise services for consumers.
Forward-looking Statements
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the
For investor and media inquiries, please contact:
info@qiliancorp.com
View original content:https://www.prnewswire.com/news-releases/bgm-to-report-first-half-2025-unaudited-financial-results-on-july-24-2025-302511878.html
SOURCE BGM Group Ltd